2019 TCT | Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR
2019 TCT Meetings Policy for Abstracts

Abstract Eligibility

  • Work submitted for presentation should not have been reported previously in an archival scientific publication, either as an article or as an abstract, at the time of submission.
  • Data that has been, or will be, presented at *any other meeting before being presented at the 2019 TCT Meetings, will not be accepted for presentation.

*Due to the overlap in abstract submission/presentation timelines for the 2018 ASH Annual Meeting, data submitted to/presented at the 2018 ASH Annual Meeting is acceptable for submission to the 2019 TCT Meetings.

Conference Registration Fee

  • Abstract presenting authors will be eligible for the Early Registration Rate even after Standard and On-Site Registration Rates apply. If your presentation is accepted, you will receive a code to use when registering that will automatically apply the reduction in your registration rate.

Abstract Submission Fee

  • There is a $40 non-refundable abstract submission fee.

2019 TCT Meetings - Abstract Categories

Abstract data/research must apply to one of the following 2019 TCT Meetings abstract categories.

Responsibility of Abstract Authors
  • The first author listed for each abstract serves as the Presenting Author and is the primary contact for all correspondence regarding the abstract.
  • The Presenting Author is responsible for the following:
    • Ensuring that all authors have read the abstract and agreed to be co-authors.
    • Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by the TCT Meetings.
    • Obtaining all of the conflict-of-interest disclosure information from co-authors.
    • Making certain that abstracts are complete (tables included and labeled) and written in clear, concise and grammatically correct English, so that reviewers are able to focus solely on the scientific merits of the submission. For authors with any question regarding the clarity, grammar or spelling of their abstract, we encourage identifying and using an independent reviewer to edit the abstract prior to submission.
    • Ensuring that he/she will be prepared to present and to respond to questions regarding the abstract. If that is not the case, the authors should choose a poster as their preference.
  • Each abstract author agrees and certifies that he or she:
    • Has read all of the rules and agrees to be bound by them.
    • Is responsible for submission of the abstract in accordance with the rules, and waives any and all claims against ASBMT/CIBMTR/TCT Meetings and any reviewer arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.

Abstract Review

Abstracts are peer reviewed on their scientific merits and according to subject category. Individuals submitting abstracts must indicate the appropriate review category. The ASBMT/CIBMTR/TCT Meetings reserve the right to make minor editorial grammatical/spelling changes if required for clarity of presentation. Abstracts may be re-categorized to a more appropriate category based on guidance from the TCT Meetings Co-Chairs.

Abstract Corrections

All changes/edits to submitted abstracts are strictly the responsibility of the first author and must be conducted within the confines of the abstract submission portal. Requests for assistance in accessing abstracts to allow for modifications, should be submitted in writing to TCTabstracts@asbmt.org.

Abstract Withdrawals

Abstract withdrawals can be made within the Speaker Center by the first author, no later than October 12, 2018. Abstract withdrawal requests after October 12, 2018 must be made, in writing only to TCTabstracts@asbmt.org. ASBMT and CIBMTR staff cannot fulfill any withdrawal requests by phone.

Accepted abstracts that remain in the submission system on November 14, 2018 may be published online and in the Biology of Blood and Marrow Transplantation, as submitted.

Incomplete Abstracts

Any submitted abstract deemed incomplete within the submission system on October 4, 2018 @ 12:01 AM PST will be eliminated without further notification prior to abstracts being distributed to the 2019 TCT Meetings Abstract Review Committees.

Late-Breaking Abstracts

The submission of late-breaking abstracts will be allowed from November 5, 2018 – December 7, 2018 @ 11:59 PM (PST).

Late-breaking abstract authors must complete a request for information to explain the need for submission during the late-breaking abstract submission process, which will be shared with the abstract reviewers and program Co-Chairs.

Accepted late-breaking abstracts will be included in 2019 TCT Meetings app and on the TCT website, but will not be included in the printed BBMT Supplement distributed at the TCT Meetings.


Abstracts submitted for presentation to the 2019 TCT Meetings will be embargoed by the author(s) and the 2019 TCT Meetings, upon submission.

The embargo will be lifted and abstracts will be made available for viewing approximately six weeks in advance of the 2019 TCT Meetings.


Authors assign copyright of the abstract to ASBMT upon submission, unless one of the authors is a U.S. Federal employee. This means that the identical abstract may not be republished or submitted to another meeting; however, Elsevier may grant permission for reuse of abstract content on behalf of ASBMT. You can request to re-use an abstract at http://www.elsevier.com/authors/permission-request-form.

Additional Information

Additional details and guidance on abstract submission for the 2019 TCT Meetings is available within the Submission Portal.